These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32045666)
1. Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review. Rajan L; Palaniswamy D; Mohankumar SK Pharmacol Res; 2020 May; 155():104681. PubMed ID: 32045666 [TBL] [Abstract][Full Text] [Related]
2. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate. El-Korany SM; Helmy OM; El-Halawany AM; Ragab YE; Zedan HH BMC Biotechnol; 2020 Oct; 20(1):52. PubMed ID: 33008398 [TBL] [Abstract][Full Text] [Related]
3. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase. Kazmi I; Afzal M; Rahman S; Iqbal M; Imam F; Anwar F Eur J Pharmacol; 2013 Jun; 709(1-3):28-36. PubMed ID: 23500199 [TBL] [Abstract][Full Text] [Related]
5. Screening of Korean medicinal plants for lipase inhibitory activity. Kim HY; Kang MH Phytother Res; 2005 Apr; 19(4):359-61. PubMed ID: 16041737 [TBL] [Abstract][Full Text] [Related]
6. Natural inhibitors of pancreatic lipase as new players in obesity treatment. de la Garza AL; Milagro FI; Boque N; Campión J; Martínez JA Planta Med; 2011 May; 77(8):773-85. PubMed ID: 21412692 [TBL] [Abstract][Full Text] [Related]
7. Lipase Inhibitors for Obesity: A Review. Liu TT; Liu XT; Chen QX; Shi Y Biomed Pharmacother; 2020 Aug; 128():110314. PubMed ID: 32485574 [TBL] [Abstract][Full Text] [Related]
8. Possible anti-obesity therapeutics from nature--a review. Yun JW Phytochemistry; 2010 Oct; 71(14-15):1625-41. PubMed ID: 20732701 [TBL] [Abstract][Full Text] [Related]
15. Water Extract of Pleurotus eryngii var. ferulae Prevents High-Fat Diet-Induced Obesity by Inhibiting Pancreatic Lipase. Jo KJ; Ghim J; Kim J; Lee H; Lee TG; Kim JI; Kim Y; Byun JW; Min BS; Son JS; Shim SG; Cheon WJ; Ryu SH J Med Food; 2019 Feb; 22(2):178-185. PubMed ID: 30657431 [TBL] [Abstract][Full Text] [Related]
16. Cetilistat, a new lipase inhibitor for the treatment of obesity. Padwal R Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108 [TBL] [Abstract][Full Text] [Related]
17. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia. Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic lipase inhibitors: The road voyaged and successes. Kumar A; Chauhan S Life Sci; 2021 Apr; 271():119115. PubMed ID: 33515565 [TBL] [Abstract][Full Text] [Related]
19. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi Y; Burn P Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736 [No Abstract] [Full Text] [Related]
20. Computational approaches for the discovery of natural pancreatic lipase inhibitors as antiobesity agents. Almasri IM Future Med Chem; 2020 Apr; 12(8):741-757. PubMed ID: 32212943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]